Thermo Fisher Scientific Announces Collaboration to Establish New Tokyo Biomarker Research Centre
Thermo Fisher Scientific Inc has announced a landmark collaboration that aims to introduce mass spectrometry-based workflows and technologies into Japan to advance personalised medicine and healthcare. The intent of the collaboration between Thermo Fisher’s Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Centre, Toshihide Nishimura, Professor at the Tokyo Medical University Hospital and Gyorgy Marko-Varga, Professor at the Tokyo Medical University Hospital and Lund University, Sweden is to establish and support a new Biomarker Research Centre in Tokyo, Japan. The new Centre will focus on biomarker discovery and quantification, disease mechanisms, therapeutic drug monitoring and disease pathophysiology.

The BRIMS Centre is the archetype for the coming Tokyo Biomarker Research Centre. The goal is to bring to the collaboration Thermo Fisher’s expertise in mass spectrometry-based assays, workflow development and technology integration, as well as its extensive network of collaborators engaged in similar research. “In Japan there is an urgent need to develop more targeted disease detection and treatments for a rapidly growing patient population,” said Murray Wigmore, Senior Director of Commercial Operations in Japan, Thermo Fisher Scientific. “The Tokyo Biomarker Research Centre will be developed as the model to replicate the excellence of BRIMS in international markets.”

The aim is for the collaboration to result in the Tokyo Biomarker Centre which will have dedicated laboratories based at Tokyo Medical. Correlation of protein expression and quantitative regulation for diseases of key concern in Japan such as lung cancer, chronic obstructive pulmonary disease (COPD) and cardiovascular disease will be performed to discover biomarker candidates related to drug response. The research centre will also house an archive with comprehensive tissue and blood sample collections, along with access to complementary clinical and demographic data. The archive will include samples from drug responder and non-responders, and material from clinical studies performed in Scandinavia and other European countries.

Chromatography & Spectroscopy

• High Throughput Screening for Phthalates in Toys and Childcare Articles Using the Agilent 6140 Single Quadrupole LC/MS System and Analytical Studio Browser Software
• Glycan Analysis Opens Up New Possibilities For Mass Spectrometry

Laboratory Products

• News Asia
• Analytica China Preview

Microscopy & Microtechnology

• Nanofabrication - European Research Labs Apply Dip Pen Nanolithography

Special Features

• Safety Cabinets & Hazard Containment
• Particle Characterisation
• Drug Discovery & Pharmaceutical Analysis